Verndari, Inc.

About Verndari An early-stage biotechnology company, Verndari was founded with the goal of transforming vaccine delivery through next-generation science and technology. Our Mission Verndari, Inc. is a biotechnology company dedicated to developing and commercializing a novel intradermal vaccine delivery device to prevent serious infectious diseases. Verndari was founded with the goal of transforming vaccine delivery through next-generation science and technology. At Verndari, we seek to improve global health through more effective delivery of vaccines, at a lower cost, to populations around the world. We aim to establish VaxiPatch™ as a proven, lifesaving solution to prevent known and emerging infectious diseases. Verndari’s unique VaxiPatch™, a single-dose vaccination kit using intradermal microarray technology, offers potential advantages that include dose sparing, improved efficacy, and pain-free delivery – while making vaccine administration much simpler. The technology eliminates the need for cold chain shipping and storage and facilitates high-volume automated manufacturing of vaccines. We are a close-knit team of innovators, many of whom have previously worked together to bring successful products to fruition at large global corporations and startup biotech companies, and have held leadership positions at pharmaceutical corporations, strategic consulting firms, defense contractors, a U.S. national laboratory, and the U.S. Army. Verndari is proud to be a female-led, Service-Disabled Veteran-Owned Small Business.